606 related articles for article (PubMed ID: 17662783)
21. Flow-dependent re-endothelialization of tissue-engineered heart valves.
Lichtenberg A; Cebotari S; Tudorache I; Sturz G; Winterhalter M; Hilfiker A; Haverich A
J Heart Valve Dis; 2006 Mar; 15(2):287-93; discussion 293-4. PubMed ID: 16607913
[TBL] [Abstract][Full Text] [Related]
22. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
23. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation.
O'Brien MF; Goldstein S; Walsh S; Black KS; Elkins R; Clarke D
Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):194-200. PubMed ID: 10660192
[TBL] [Abstract][Full Text] [Related]
24. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
[TBL] [Abstract][Full Text] [Related]
25. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
26. Biomatrix/polymer composite material for heart valve tissue engineering.
Stamm C; Khosravi A; Grabow N; Schmohl K; Treckmann N; Drechsel A; Nan M; Schmitz KP; Haubold A; Steinhoff G
Ann Thorac Surg; 2004 Dec; 78(6):2084-92; discussion 2092-3. PubMed ID: 15561041
[TBL] [Abstract][Full Text] [Related]
27. Construction of autologous human heart valves based on an acellular allograft matrix.
Cebotari S; Mertsching H; Kallenbach K; Kostin S; Repin O; Batrinac A; Kleczka C; Ciubotaru A; Haverich A
Circulation; 2002 Sep; 106(12 Suppl 1):I63-I68. PubMed ID: 12354711
[TBL] [Abstract][Full Text] [Related]
28. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
[TBL] [Abstract][Full Text] [Related]
29. Heart valve tissue engineering.
Neuenschwander S; Hoerstrup SP
Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
[TBL] [Abstract][Full Text] [Related]
30. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
[TBL] [Abstract][Full Text] [Related]
31. Fibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve.
Ota T; Sawa Y; Iwai S; Kitajima T; Ueda Y; Coppin C; Matsuda H; Okita Y
Ann Thorac Surg; 2005 Nov; 80(5):1794-801. PubMed ID: 16242457
[TBL] [Abstract][Full Text] [Related]
32. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
[TBL] [Abstract][Full Text] [Related]
33. Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model.
Hayashida K; Kanda K; Yaku H; Ando J; Nakayama Y
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):152-9. PubMed ID: 17599501
[TBL] [Abstract][Full Text] [Related]
34. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure.
Dohmen PM; Lembcke A; Holinski S; Kivelitz D; Braun JP; Pruss A; Konertz W
Ann Thorac Surg; 2007 Sep; 84(3):729-36. PubMed ID: 17720368
[TBL] [Abstract][Full Text] [Related]
35. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves.
Kasimir MT; Rieder E; Seebacher G; Nigisch A; Dekan B; Wolner E; Weigel G; Simon P
J Heart Valve Dis; 2006 Mar; 15(2):278-86; discussion 286. PubMed ID: 16607912
[TBL] [Abstract][Full Text] [Related]
36. [Preliminary in vivo evaluation of tissue engineered venous grafts fabricated based on endothelial progenitor cells].
Wu YF; Zhang J; Gu YQ; Li JX; Chen XS; Chen L; Chen B; Guo LR; Luo T; Liao CJ; Wu X; Yu HX; Wang ZG
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):491-5. PubMed ID: 17686312
[TBL] [Abstract][Full Text] [Related]
37. Tissue engineering of heart valves in vivo using bone marrow-derived cells.
Kim SS; Lim SH; Hong YS; Cho SW; Ryu JH; Chang BC; Choi CY; Kim BS
Artif Organs; 2006 Jul; 30(7):554-7. PubMed ID: 16836737
[TBL] [Abstract][Full Text] [Related]
38. Fabrication of biomatrix/polymer hybrid scaffold for heart valve tissue engineering in vitro.
Hong H; Dong GN; Shi WJ; Chen S; Guo C; Hu P
ASAIO J; 2008; 54(6):627-32. PubMed ID: 19033778
[TBL] [Abstract][Full Text] [Related]
39. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
Shinoka T; Ma PX; Shum-Tim D; Breuer CK; Cusick RA; Zund G; Langer R; Vacanti JP; Mayer JE
Circulation; 1996 Nov; 94(9 Suppl):II164-8. PubMed ID: 8901739
[TBL] [Abstract][Full Text] [Related]
40. Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions.
Lichtenberg A; Tudorache I; Cebotari S; Suprunov M; Tudorache G; Goerler H; Park JK; Hilfiker-Kleiner D; Ringes-Lichtenberg S; Karck M; Brandes G; Hilfiker A; Haverich A
Circulation; 2006 Jul; 114(1 Suppl):I559-65. PubMed ID: 16820637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
